Social Pulse: Optimer Pharmaceuticals Inc (OPTR.OQ)
OPTR.OQ on NASDAQ Stock Exchange Global Select Market
12.48USD
1 Aug 2013
12.48USD
1 Aug 2013
Price Change (% chg)
$-0.03 (-0.24%)
$-0.03 (-0.24%)
Prev Close
$12.51
$12.51
Open
$12.64
$12.64
Day's High
$12.65
$12.65
Day's Low
$12.48
$12.48
Volume
558,582
558,582
Avg. Vol
327,918
327,918
52-wk High
$16.77
$16.77
52-wk Low
$8.66
$8.66
- Cubist Pharmaceuticals: 2 Promising Deals To Bolster Future Pipeline
- The Deal: Cubist Commits $1.6B to Bolster Antibiotics Portfolio
- Cubist Becomes Dominant Antibiotic Seller With Optimer, Trius Buys
- Coming Soon: Optimer Pharmaceuticals Earnings
- 5 Stocks Poised for Breakouts
- Deadly Bacteria Is A Global Crisis: Brad Spellberg
Press Releases
- Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
- Optimer Pharmaceuticals and AstraZeneca Collaborate to Commercialize Fidaxomicin for Clostridium Difficile Infection in Latin America
- Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
- Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
- Optimer Initiates Phase 3b Clinical Trial of DIFICIDĀ® for the Prevention of Clostridium difficile-Associated Diarrhea in Bone Marrow Transplant Patients

